{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:27:26Z","timestamp":1775215646323,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T00:00:00Z","timestamp":1255564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold>Ketobemidone is often used as an alternative to morphine in children in the Scandinavian countries. The aim of this clinical trial was to explore the pharmacokinetics of ketobemidone in children because these properties have not been reported previously.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>Thirty children, newborn to 10 years, scheduled for elective surgery were included in the trial. Ketobemidone hydrochloride was administered as a single intravenous bolus dose and ketobemidone and norketobemidone concentrations were measured by LC\u2010MS over 8\u2003h. Pharmacokinetic parameters were determined using compartmental methods.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>Six children were excluded from pharmacokinetic analysis because of incomplete blood sampling. The values of ketobemidone clearance (l\/h\/kg) given as median (range) were 0.84 (0.29\u20133.0) in Group A (0\u201390 days), 0.89 (0.55\u20131.35) in Group B (1\u20132.5 years) and 0.74 (0.50\u20130.99) in Group C (7\u201310 years). The corresponding values for apparent volume of distribution (l\/kg) were 4.4 (3.7\u20136.9) (Group A), 2.6 (2.0\u20135.6) (Group B) and 3.9 (2.7\u20135.0 (Group C), and for elimination half\u2010life (h) 3.0 (1.4\u20138.9) (Group A), 2.0 (1.2\u20134.7) (Group B) and 3.7 (2.4\u20136.9) (Group C), respectively. In the two neonates the elimination half\u2010life was almost 9\u2003h. The metabolite norketobemidone did not reach levels above the limit of quantification (0.07\u2003ng\/ml) in any of the patients.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold>The pharmacokinetic parameters of ketobemidone in children older than 1 month appear to be similar to those in adults. Because of the large interindividual variability of the pharmacokinetics in neonates, further studies especially in this age group are warranted.<\/jats:p>","DOI":"10.1111\/j.1399-6576.2009.02135.x","type":"journal-article","created":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T09:32:57Z","timestamp":1255599177000},"page":"435-441","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacokinetics after an intravenous single dose of the opioid ketobemidone in children"],"prefix":"10.1111","volume":"54","author":[{"given":"S.","family":"LUNDEBERG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"STEPHANSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"LAFOLIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"OLSSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.\u2010O.","family":"STILLER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"EKSBORG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,25]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1256","article-title":"Comparison of the analgesic efficacy of ketobemidone and morphine for management of postoperative pain in children","volume":"48","author":"Jylli L","year":"2004","journal-title":"a randomized, controlled study"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1993.tb01363.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(96)03123-5"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)11364-3"},{"key":"e_1_2_6_6_2","first-page":"252","article-title":"Patient\u2010controlled analgesic therapy, Part III","volume":"7","author":"Tamsen A","year":"1982","journal-title":"pharmacokinetics and analgesic plasma concentrations of ketobemidone"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1982.tb01848.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561676"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561953"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0090-9556(25)06162-8","article-title":"Quantitative determination of the urinary excretion of ketobemidone and four of its metabolites after intravenous and oral administration in man","volume":"9","author":"Bondesson U","year":"1981","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(05)70463-6"},{"key":"e_1_2_6_12_2","volume-title":"The Growth of the surface area of the human body","author":"Boyd E.","year":"1935"},{"key":"e_1_2_6_13_2","first-page":"1","volume-title":"User verification of performance and trueness; approved guideline. CLSI document EP15\u2010A2","author":"Carey R","year":"2005"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeh042"},{"key":"e_1_2_6_15_2","first-page":"5","article-title":"Recommended use of morphine in neonates, infants and children based on a literature review","volume":"7","author":"Kart T","year":"1997","journal-title":"part 1-pharmacokinetics"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1994.tb12976.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1996.tb00250.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/00498250500183181"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1997.00625.x"},{"key":"e_1_2_6_20_2","first-page":"110","article-title":"Propofol decreases the clearance of midazolam by inhibiting CYP3A4","volume":"66","author":"Hamaoka N","year":"1999","journal-title":"an in vivo and in vitro study"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/78.5.601"},{"key":"e_1_2_6_22_2","first-page":"1098","article-title":"Simplified calculation of body\u2010surface area","volume":"31","author":"Mosteller RD.","year":"1987","journal-title":"N Engl J Med"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200004000-00002"},{"key":"e_1_2_6_24_2","first-page":"240","article-title":"Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherap","volume":"38","author":"Eksborg S","year":"2002","journal-title":"can intravenous acyclovir be substituted by oral valacyclovir?"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.2009.02135.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.2009.02135.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T19:37:29Z","timestamp":1739389049000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.2009.02135.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,25]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1399-6576.2009.02135.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.2009.02135.x","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"value":"0001-5172","type":"print"},{"value":"1399-6576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,25]]}}}